Evidence map›Paper›PMID 29869084›Full record

Observational studySurgical endoscopy2018

Cost-effectiveness analysis of laparoscopic versus open surgery in colon cancer.

Javier Mar, Ane Anton-Ladislao, Oliver Ibarrondo, Arantzazu Arrospide, Santiago Lázaro, Nerea Gonzalez, Marisa Bare, Daniel Callejo, Maximino Redondo, José M Quintana and 1 more

Registry-linked trialAbstract readComparative StudyMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Surgical endoscopy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02488161 (Risk Factors of Adverse Outcomes at Short and Medium Term, and Development of Predictive Models, in Patients With Colorectal Cancer. IRYSS-coordinated Multicenter Study), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02488161 completednot on this map

Risk Factors of Adverse Outcomes at Short and Medium Term, and Development of Predictive Models, in Patients With Colorectal Cancer. IRYSS-coordinated Multicenter Study

TypeobservationalSponsorHospital Galdakao-UsansoloRan2010 to 2015Enrolled2,600ConditionsColorectal CancerArmsNo intervention
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Colorectal cancer: Recent advances in management and treatment.World journal of clinical oncology · 2024
    Review
  3. Article
  4. Biotechnologia · 2024
    Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Javier MarUnidad de Investigación AP-OSIs Gipuzkoa, Hospital Alto Deba, Mondragón, Spain. javier.marmedina@osakidetza.eus.ORCID 0000-0002-9455-4869
Ane Anton-LadislaoUnidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
Oliver IbarrondoUnidad de Investigación AP-OSIs Gipuzkoa, Hospital Alto Deba, Mondragón, Spain.
Arantzazu ArrospideUnidad de Investigación AP-OSIs Gipuzkoa, Hospital Alto Deba, Mondragón, Spain.
Santiago LázaroServicio de Cirugía General, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
Nerea GonzalezUnidad de Investigación, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
Marisa BareUnidad de Epidemiología Clínica, Corporacio Parc Tauli, Barcelona, Spain.
Daniel CallejoHealth Technology Assessment Unit, Lain Entralgo Agency, Madrid, Spain.
Maximino RedondoUnidad de Investigación, Hospital Costa del Sol, Malaga, Spain.
José M QuintanaUnidad de Investigación AP-OSIs Gipuzkoa, Hospital Alto Deba, Mondragón, Spain.
REDISSEC-CARESS/CCR group
Centro de Investigación Biomédica en Red · ESHospital Alto Deba · ESHospital Costa del Sol · ESHospital de Galdakao · ESInstituto Químico Biológico · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFew economic evaluations have assessed laparoscopy for colon cancer. This study aimed to compare the cost-effectiveness of laparoscopic and open surgery for the treatment of colon cancer.

methodA cost-effectiveness analysis was performed comparing two groups of patients treated according to standard clinical practice (REDISSEC-CARESS/CCR cohort) by laparoscopic or open surgery. Data were collected from health records on clinical characteristics and resource use over 2 years after surgery. To calculate the incremental cost-effectiveness ratio, costs and quality-adjusted life years (QALYs) were obtained for each patient. Clinical heterogeneity was addressed using propensity score and joint multivariable analysis (seemingly unrelated regression) that included interactions between TNM stage, age, and surgical procedure to perform subgroup analysis.

resultsThe sample was composed of 1591 patients, 963 who underwent laparoscopy and 628 open surgery. Using propensity score and regression analysis, we found that laparoscopy was associated with more QALYs and less resource use than open surgery (0.0163 QALYs, 95% CI 0.0114-0.0212; and - €3461, 95% CI - 3337 to - 3586). Costs were lower for laparoscopy in all subgroups. In the subgroups younger than 80 years old, utility was higher in patients who underwent laparoscopy. Nevertheless, open surgery had better outcomes in older patients in stages I-II (0.0618 QALYs) and IV (0.5090 QALYs).

conclusionOverall, laparoscopy appears to be dominant, resulting in more QALYs and lower costs. Nevertheless, while laparoscopy required fewer resources in all subgroups, outcomes may be negatively affected in elderly patients, representing an opportunity for shared decision making between surgeons and patients. ClinicalTrials.gov Identifier: NCT02488161.

Indexed as

Hospital CostsAgedAged, 80 and overColectomyColonic NeoplasmsCost-Benefit AnalysisFemaleHumansLaparoscopyMaleMiddle AgedProspective StudiesQuality-Adjusted Life YearsColon cancerCost-effectivenessLaparoscopyOpen surgery

Identifiers

PMID29869084
OpenAlexW2806569086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.